As the first oral dual GLP-1 and amylin agonist, Amycretin promises significant weight loss with up to 24% body-weight reduction in 36 weeks via injections, and 13% over 12 weeks in pill form. But when can you get Amycretin in the UK and where? Here’s everything you need to know.

Table of Contents

Launch Timeline in the UK

Amycretin is not yet available in the UK. It has completed Phase 1b/2a and will enter Phase 3 trials in early 2026.

Regulatory approval via MHRA/NICE could take until 2029–2030.

Novo Nordisk expects approval “within this decade” and is developing both subcutaneous and oral versions simultaneously.

For context, patients interested in weight-loss treatments can explore alternatives like Orforglipron oral weight loss GLP-1 tablets which are in development as well.

How & Where You’ll Access It

Once approved, Amycretin will be a prescription-only medication, dispensed through:

– MedCare Health Clinic (Preston) – Our clinic will offer consultations and prescriptions for UK-approved Amycretin.
– Partnered Pharmacies in Preston & Lancashire – We’ll work with our local pharmacies to supply both injection and oral options.
– Online Private Prescription – Through our clinic’s secure platform, eligible patients can get prescriptions and have Amycretin delivered discreetly.

Patients can expect support from initial assessment to ongoing follow-up ensuring safety and maximised effectiveness tailored to individual health goals.

💡 Why MedCare Is Ideal for Amycretin Patients

– Expert Clinicians: Pharmacist-led prescribing ensures tailored treatment plans.
– Holistic Support: Ongoing advice on diet, lifestyle, and managing side effects.
– Convenience: Virtual consultations covering the whole of UK and access points across Preston and Lancashire.

For those considering medical weight loss, our weight management treatments provide guidance and prescription support.

What to Do Next in Preston

– Stay informed: Keep an eye on MedCare updates regarding Phase 3 results and MHRA approval.
– Sign up early: Register for notifications when prescribing becomes possible.
– Prepare your medical history: Weight loss medications require BMI, health conditions, and medication review.
– Book a consultation: Once available, consult MedCare to check eligibility and begin treatment.

You may also want to review other GLP-1 based options such as weight loss injections, already available in the UK.

Summary Table

Phase	Timeline	What It Means
Phase 3 Trials	Early 2026	Final clinical testing
MHRA/NICE Approval	2029–2030 (estimate)	Legal UK launch
MedCare rollout	Shortly after approval	Prescriptions
Patient support	From day one	Clinic + pharmacy + online follow-up

MedCare Health Clinic in Preston is committed to guiding you seamlessly for your weight loss journey.